VAT Refund Claims for Imported Exempt Medicines Need Proof the Input VAT Was Not Used

Medicine importers must prove VAT paid on exempt importations was not claimed as input tax credit, or their refund claim may be denied. Importers claiming a refund or tax credit for VAT paid on VAT-exempt medicines must be ready to prove, through traceable VAT returns, ledgers, and reconciliations, that the same VAT was not already […]

RMC No. 100-2024: FDA-Endorsed Updates to VAT-Exempt Medicines for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, and Tuberculosis

RMC No. 100-2024 publishes FDA updates to VAT-exempt medicines and confirms exemption applies from the FDA publication date of the updated list. Businesses selling, purchasing, prescribing, distributing, or accounting for covered medicines must immediately check whether their products are included in the updated FDA-endorsed list of VAT-exempt products, because VAT exemption under RMC No. 100-2024 […]

RMC No. 157-2022: Updated VAT-Exempt Medicines List for Mental Illness and COVID-19 Treatment Under the CREATE Act

RMC No. 157-2022 updates the VAT-exempt medicines list under the CREATE Act, covering certain mental illness and COVID-19 treatment medicines. Pharmacies, hospitals, clinics, drug distributors, and sellers of covered medicines must verify whether their products are included in the updated List of VAT-Exempt Medicines because the VAT exemption applies only from the date the Food […]

RMC No. 156-2022: Updates to VAT-Exempt Medicines List for Common and Chronic Illnesses

RMC No. 156-2022 updates the VAT-exempt medicines list under the CREATE Act, covering chronic and life-threatening conditions. Businesses must adjust VAT calculations immediately. Businesses and healthcare providers must now adjust their VAT calculations immediately for certain medicines prescribed for hypertension, diabetes, high cholesterol, tuberculosis, mental illness, and cancer. The Food and Drug Administration’s latest update, […]

RMC No. 129-2022: Updates to VAT-Exempt Medicines List Affecting Mental Health Prescriptions

RMC No. 129-2022 updates the VAT-exempt medicines list under the CREATE Act, removing certain mental health medicines and requiring businesses to apply 12% VAT immediately. Businesses in the pharmaceutical sector, healthcare providers, and distributors must take immediate note: certain medicines previously exempt from VAT under Republic Act No. 11534 (CREATE Act) are now removed from […]

RMC No. 125-2022: Updated FDA List Deletes Certain COVID-19 Treatment Medicines from CREATE Act VAT Exemption

RMC No. 125-2022 updates the FDA VAT-exempt medicines list, deleting certain COVID-19 treatment medicines under the CREATE Act. Businesses selling, purchasing, importing, distributing, prescribing, or accounting for medicines used in COVID-19 treatment must immediately re-check the current FDA-published List of VAT-Exempt Medicines before treating those medicines as VAT-exempt. RMC No. 125-2022 makes a critical update […]

RMC No. 119-2022: VAT Exemption for Newly Endorsed COVID-19 Medicines

RMC No. 119-2022 adds Nirmatrelvir + Ritonavir 150 mg + 100 mg tablets for COVID-19 to the VAT-exempt list, effective from FDA publication, impacting healthcare providers and distributors. Businesses and healthcare providers must update their VAT-exempt inventory immediately: the Food and Drug Administration has added Nirmatrelvir + Ritonavir 150 mg + 100 mg film-coated tablets […]

RMC No. 113-2022: Updates to VAT-Exempt Medicines under the CREATE Act Affecting COVID-19 Treatments

RMC No. 113-2022 updates the VAT-exempt medicines list under the CREATE Act, correcting and deleting certain COVID-19 treatments, effective July 1, 2022. Businesses must adjust VAT filings accordingly. Businesses dealing with pharmaceutical sales must immediately review their VAT compliance for medicines prescribed for COVID-19. Recent updates endorsed by the Food and Drug Administration now correct […]

RMC No. 112-2022: FDA-Endorsed Updates to VAT-Exempt Medicines Affecting Tuberculosis Treatments

RMC No. 112-2022 updates the VAT-exempt medicines list under the CREATE Act, adding tuberculosis medicines and removing COVID-19 medicines, affecting tax compliance for healthcare providers. Businesses in the pharmaceutical and healthcare sectors must immediately update their records and compliance processes due to the newly endorsed changes to the VAT-exempt medicines list. Certain medicines prescribed for […]

RMC No. 58-2022: Updates to VAT-Exempt Medicines List Including Hypertension and COVID-19 Treatments

RMC No. 58-2022 publishes FDA corrections to VAT-exempt medicines, affecting hypertension and COVID-19 treatments. Businesses must update records and invoices to remain compliant. Businesses and healthcare providers must immediately note changes to the VAT-exempt status of certain medicines. RMC No. 58-2022 publishes the FDA’s updates correcting names of specific medicines used for hypertension and COVID-19 […]